women who require surgery are not being properly informed that a commonly used anesthetic may reduce the effectiveness of their birth control, according to a new study that warns the omission may result in unwanted pregnancies.
the research, which was presented at the annual meeting of the
european society of anaesthesiology and intensive care (esaic)
in italy, found that robust methods for identifying women of child-bearing age and informing them of these risks was not common in the u.k. and, likely, elsewhere.
sugammadex, a drug widely used in anesthesia, is typically administered to patients toward the end of a medical procedure to reverse the effects of muscle relaxants delivered prior to surgery. according to the study, this drug is known to interact with the hormone progesterone in a way that can reduce the effectiveness of hormonal contraceptives, including the progesterone-only pill (mini-pill), combined pill, implants, vaginal rings and intra-uterine devices.
women of child-bearing age should be warned of anesthetic risk
current guidance requires women of child-bearing age to be informed of the risks that accompany sugammadex and for them to be advised to follow the missed-pill advice included in the information that comes with hormonal contraceptives. they are also encouraged to use a non-hormonal method of contraception, if required, for the next seven days.